Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Down 5.1% in December

Intelligent Bio Solutions Inc. (NASDAQ:INBS) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 427,400 shares, a drop of 5.1% from the December 15th total of 450,500 shares. Currently, 9.1% of the shares of the company are sold short. Based on an average daily volume of 118,600 shares, the days-to-cover ratio is presently 3.6 days.

Intelligent Bio Solutions Trading Up 6.1 %

Intelligent Bio Solutions stock opened at $1.39 on Tuesday. Intelligent Bio Solutions has a 52 week low of $1.00 and a 52 week high of $11.70. The business’s 50-day simple moving average is $1.48 and its 200-day simple moving average is $1.52.

Intelligent Bio Solutions (NASDAQ:INBS) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.53) by ($0.17). Intelligent Bio Solutions had a negative return on equity of 147.50% and a negative net margin of 288.35%. The business had revenue of $872.29 million during the quarter. As a group, research analysts predict that Intelligent Bio Solutions will post -1.25 earnings per share for the current year.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.